Skip to main content
. 2018 Oct 30;37(8):1733–1738. doi: 10.1007/s00345-018-2539-5

Table 1.

Summary and results of our material. Follow-up at 6 months and at 36 months after the last dilatation

Etiology n/N (%) Ureter location n/N (%) Stricture length (cm) Number of primary dilatation n/N (%) Dilatation method n/N (%) Success rate n/N (%)
P M D < 2 cm > 2 cm 1 × 2 × Balloon Catheter Ho. laser 6 months 36 months
Benign 14/43 (32%)
 Idiopathic 6/14 (43%) 2 4 6 5 1 4 2
 Lithiasis 5/14 (36%) 2 3 5 5 3 2
 Urinary diversion for neurogenic bladder 1/14 (7%) 1 1 1 1
 Pyelo-ureteric junction obstruction 1/14 (7%) 1 1 1 1
 Collagen colitis 1/14 (7%) 1 1 1
Total 5/14 (36%) 9/14 (64%) 14/14 (100%) 13/14 (93%) 1/14 (7%) 9/14 (64%) 4/14 (28%) 1/14(8%) 13/14 (93%) 13/14 (93%)
Post-malignant 29/43 (68%)
 Surgery and radiotherapy 8/29 (27%) 2 6 3 5 6 2 7 1
 Radical cystectomy 6/29 (21%) 6 2 4 6 6
 Radical prostatectomy 4/29 (14%) 4 2 2 3 1 2 2
 Radiotherapy 3/29 (10%) 3 2 1 2 1 1 2
 BCG/Mitomycin (UTUC) 4/29 (14%) 4 3 1 3 1 4
 Distal ureter malignancy 4/29 (14%) 4 3 1 3 1 3 1
Total 2/29 (7%) 27/29 (93%) 15/29 (52%) 14/29 (48%) 23/29 (79%) 6/29 (21%) 23/29 (79%) 6/29 (21%) 21/29 (72%) 18/29 (62%)a
Overall 5/43 (12%) 2/43 (4%) 36/43 (84%) 29/43 (67%) 14/43 (33%) 36/43 (84%) 7/43 (16%) 32/43 (74%) 10/43 (23%) 1/43 (3%) 34/43 (79%) 31/43 (72%)

D distal ureter, M mid ureter, P proximal ureter, Ho holmium, UTUC upper tract urothelial carcinoma, 1 × one dilatation, 2 × two dilatations

aThree recurrences failed re-dilatation